Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 8 Nov 2010 |
| Articles of Association | 27 Oct 2010 |
| Genmab Announces Start of Ofatumumab Phase III Head to Head Study in Follicular Lymphoma | 26 Oct 2010 |
| Genmab Announces Reorganization Plan | 25 Oct 2010 |
| Arzerra Third Quarter 2010 Net Sales Figures | 21 Oct 2010 |